Tuesday, January 28, 2014

Pfizer Q4 and Full Year Report 2013

PFIZER REPORTS FOURTH-QUARTER AND FULL-YEAR 2013 RESULTS;
PROVIDES 2014 FINANCIAL GUIDANCE

  • Fourth-Quarter 2013 Reported Revenues of $13.6 Billion (13.9), Full-Year 2013 Reported Revenues of $51.6 Billion (54.7).
  • Fourth-Quarter 2013 Adjusted Diluted EPS of $0.56 (0.46), Reported Diluted EPS of $0.39 (0.89), Full-Year 2013 Adjusted Diluted EPS of $2.22 (2.10), Reported Diluted EPS(1) of $3.19 (1.94).
  • Repurchased $4.6 Billion and $16.3 Billion of Common Stock in Fourth-Quarter and Full-Year 2013, Respectively; Returned Approximately $23 Billion to Shareholders Through Share Repurchases and Dividends in 2013.

Pfizer's 2014 financial guidance:

  • Adjusted Revenues: $49.2 to $51.2 billion
  • Reported Diluted EPS: $1.57 to $1.72
  • Adjusted Diluted EPS: $2.20 to $2.30


For more information, click the link below
Pfizer Q4-2013

3 comments:

  1. Greetings Hawk! I was surprised earnings came in as strong as they did. I sold last year because I wanted to raise some cash, but I think management is generally doing the right things. You can't fault the dividend, and with a 26% payout it should continue to climb. I wonder if they will spin off any more divisions?

    Would you mind changing your blogger comment settings to allow "name/url"? I would appreciate it. Have a great day
    -Bryan

    ReplyDelete
    Replies
    1. Hi Bryan! Surprised me also. Those future spin off, time will show! Settings changed, hopefully will work now, good day for you too.
      DH

      Delete

You might also like